FDA recall D-0732-2016

Teva North America · Class II · drug

Product

Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bottle, Manufactured in Czech Republic by: Teva Czech Industries sro, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7474-89

Reason for recall

Failed Dissolution Specifications: low test results at the 18 month time-point

Distribution

Nationwide

Key facts

Status
Terminated
Initiation date
2015-12-21
Report date
2016-03-09
Termination date
2017-01-13
Voluntary/Mandated
Voluntary: Firm initiated
Location
Horsham, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0732-2016